Roswell Park Spinoff Company Advances Toward New Clinical Trial for Brain Cancer Immunotherapy SurVaxM
November 20, 2019
November 20, 2019
BUFFALO, New York, Nov. 20 -- The Roswell Park Comprehensive Cancer Center issued the following news release:
* * *
- MimiVax LLC and Roswell Park to launch large clinical trial at centers in U.S. & abroad following major licensing deal
* * *
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC princip . . .
* * *
- MimiVax LLC and Roswell Park to launch large clinical trial at centers in U.S. & abroad following major licensing deal
* * *
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC princip . . .